Here we review your favorite and most-read pieces from all five of our partnered journals in 2018, giving you access to the most popular articles over the last year.
Want to find out what’s been happening this year? Editor, Sharon Salt, highlights the best of 2018’s neuroscience and neurology research in an A–Z.
Aoife Kiely, from our partner Alzheimer’s Society (London, UK), provides us with an overview on Brains for Dementia Research.
This week we look at NurOwn® for multiple sclerosis, a combination therapy failing to meet primary endpoint for glioblastoma and warnings from the US FDA.
Find out more about how we marked World Alzheimer’s Month this year, including our fundraising event, campaign and #TalkDementia Twitter chat.
Join those affected by dementia, researchers and charities on our #VoicesForDementia campaign, as we try to defeat the disease!
This week we look at a new migraine medicine, a rescheduling of cannabidiol for epilepsy and a successful trial for neuromyelitis optica spectrum disorder.
We look at some of the highlights of our Twitter chat (#TalkDementia), where we questioned Tara Spires-Jones, Adam Smith, Hannah Churchill, George Rook and Julie Hayden about all things dementia – from research to social stigma.
In this week’s round-up, we cover the latest industry news from the US FDA and the halt of an Alzheimer’s drug following a toxic reaction.
In the lead up to World Alzheimer’s Day, we’ve organized an office fundraising event in order to raise money for dementia research.